Kravcik S - Search Results

1

Decreased HIV-associated T cell apoptosis by HIV protease inhibitors.

Phenix BN, Angel JB, Mandy F, Kravcik S, Parato K, Chambers KA, Gallicano K, Hawley-Foss N, Cassol S, Cameron DW, Badley AD. Phenix BN, et al. Among authors: kravcik s. AIDS Res Hum Retroviruses. 2000 Apr 10;16(6):559-67. doi: 10.1089/088922200308972. AIDS Res Hum Retroviruses. 2000. PMID: 10777146

2

Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10.

Parato KG, Kumar A, Badley AD, Sanchez-Dardon JL, Chambers KA, Young CD, Lim WT, Kravcik S, Cameron DW, Angel JB. Parato KG, et al. Among authors: kravcik s. AIDS. 2002 Jun 14;16(9):1251-6. doi: 10.1097/00002030-200206140-00007. AIDS. 2002. PMID: 12045490 Clinical Trial.

3

Development of cervical fat pads following therapy with human immunodeficiency virus type 1 protease inhibitors.

Roth VR, Kravcik S, Angel JB. Roth VR, et al. Among authors: kravcik s. Clin Infect Dis. 1998 Jul;27(1):65-7. doi: 10.1086/514639. Clin Infect Dis. 1998. PMID: 9675453

4

Effect of antiretroviral therapy and viral load on the perceived risk of HIV transmission and the need for safer sexual practices.

Kravcik S, Victor G, Houston S, Sutherland D, Garber GE, Hawley-Foss N, Angel JB, Cameron DW. Kravcik S, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Oct 1;19(2):124-9. doi: 10.1097/00042560-199810010-00004. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9768620

5

Dynamic correlation of apoptosis and immune activation during treatment of HIV infection.

Badley AD, Parato K, Cameron DW, Kravcik S, Phenix BN, Ashby D, Kumar A, Lynch DH, Tschopp J, Angel JB. Badley AD, et al. Among authors: kravcik s. Cell Death Differ. 1999 May;6(5):420-32. doi: 10.1038/sj.cdd.4400509. Cell Death Differ. 1999. PMID: 10381636

6

Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir.

Kravcik S, Gallicano K, Roth V, Cassol S, Hawley-Foss N, Badley A, Cameron DW. Kravcik S, et al. J Acquir Immune Defic Syndr. 1999 Aug 15;21(5):371-5. J Acquir Immune Defic Syndr. 1999. PMID: 10458617 Clinical Trial.

7

Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression.

Angel JB, Parato KG, Kumar A, Kravcik S, Badley AD, Fex C, Ashby D, Sun E, Cameron DW. Angel JB, et al. Among authors: kravcik s. J Infect Dis. 2001 Feb 15;183(4):546-54. doi: 10.1086/318547. Epub 2001 Jan 12. J Infect Dis. 2001. PMID: 11170979 Clinical Trial.

8

Activity of the combination of nelfinavir and saquinavir against human immunodeficiency virus after failure of prior protease inhibitor therapy.

Kravcik S, Victor G, Angel JB, Badley AD, Garber GE, Cameron DW. Kravcik S, et al. Clin Infect Dis. 1999 Sep;29(3):702-3. doi: 10.1086/598671. Clin Infect Dis. 1999. PMID: 10530484 No abstract available.

9

Virological evaluation of the 'Ottawa case' indicates no evidence for HIV-1 superinfection.

Angel JB, Hu YW, Kravcik S, Tsui R, Lee KH, Barbour J, Balaskas E, Branson BM, Delwart EL, Grant RM. Angel JB, et al. Among authors: kravcik s. AIDS. 2004 Jan 23;18(2):331-4. doi: 10.1097/00002030-200401230-00027. AIDS. 2004. PMID: 15075555

10

Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4+ T-cell count < 200 cells/microl when viral replication is suppressed.

D'Egidio GE, Kravcik S, Cooper CL, Cameron DW, Fergusson DA, Angel JB. D'Egidio GE, et al. Among authors: kravcik s. AIDS. 2007 Aug 20;21(13):1711-5. doi: 10.1097/QAD.0b013e32826fb6fc. AIDS. 2007. PMID: 17690568

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters